Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2020 Filed Feb 25, 2020 21:31 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 489 | $26.20 | $12,811.80 |
DisclosureSEC source: 0000784199-20-000041 · certent-form4.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,603 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:31 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000041 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,092 F2 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:31 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 2,328 | $26.20 | $60,993.60 |
DisclosureSEC source: 0000784199-20-000041 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,844 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:13 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
GrantStock Option(Right to Buy) · Derivative | 15,432 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000037 · certent-form4.xml · derivative · entry 2 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,432 Underlying: Common Stock · 15,432 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:13 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
GrantCommon Stock | 5,081 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000037 · certent-form4.xml · nonDerivative · entry 1 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,331 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:10 UTC |
Mackin James PPresident & CEO
|
GrantStock Option(Right to Buy) · Derivative | 86,296 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000033 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,296 Underlying: Common Stock · 86,296 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:10 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 28,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000033 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,146 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:11 UTC |
Maier Dennis BVice President, Operations
|
GrantStock Option(Right to Buy) · Derivative | 9,645 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000035 · certent-form4.xml · derivative · entry 2 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,645 Underlying: Common Stock · 9,645 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:11 UTC |
Maier Dennis BVice President, Operations
|
GrantCommon Stock | 3,176 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000035 · certent-form4.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,985 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:07 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantStock Option(Right to Buy) · Derivative | 10,610 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000029 · certent-form4.xml · derivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,610 Underlying: Common Stock · 10,610 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:07 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 3,493 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000029 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,822 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:09 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantStock Option(Right to Buy) · Derivative | 21,219 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000031 · certent-form4.xml · derivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,219 Underlying: Common Stock · 21,219 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:09 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 6,987 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000031 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,552 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:02 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option(Right to Buy) · Derivative | 16,975 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000027 · certent-form4.xml · derivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,975 Underlying: Common Stock · 16,975 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:02 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 5,589 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000027 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,809 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:58 UTC |
Getz Matthew AVP, Human Resources
|
GrantStock Option(Right to Buy) · Derivative | 9,645 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000025 · certent-form4.xml · derivative · entry 2 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,645 Underlying: Common Stock · 9,645 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:58 UTC |
Getz Matthew AVP, Human Resources
|
GrantCommon Stock | 3,176 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000025 · certent-form4.xml · nonDerivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,176 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:56 UTC |
Davis John ESenior VP, Global Sales
|
GrantStock Option(Right to Buy) · Derivative | 16,204 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000023 · certent-form4.xml · derivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,204 Underlying: Common Stock · 16,204 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:56 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 5,335 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000023 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,172 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:55 UTC |
Capps Scott BVP, Clinical Research
|
GrantStock Option(Right to Buy) · Derivative | 9,645 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000021 · certent-form4.xml · derivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,645 Underlying: Common Stock · 9,645 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:55 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 3,176 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000021 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,071 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:13 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionStock Options(Right to buy) · Derivative | 8,458 | $9.64 Strike: $9.64 | $81,535.12 |
DisclosureSEC source: 0000784199-20-000004 · certent-form4.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 8,458 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (September 10, 2015) Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:13 UTC |
Holloway Jean FVP, General Counsel
|
SaleCOMMON STOCK | 8,458 | $30.00 | $253,744.23 |
DisclosureSEC source: 0000784199-20-000004 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,864 F1 · price: Reflects the price of $30.00059 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:13 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCOMMON STOCK | 8,458 | $9.64 | $81,535.12 |
DisclosureSEC source: 0000784199-20-000004 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:28 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionStock Options (Right to buy) · Derivative | 195 | $9.64 Strike: $9.64 | $1,879.80 |
DisclosureSEC source: 0000784199-20-000002 · certent-form4.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 195 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (September 10, 2015) Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:28 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 195 | $9.64 | $1,879.80 |
DisclosureSEC source: 0000784199-20-000002 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:28 UTC |
Holloway Jean FVP, General Counsel
|
SaleCommon Stock | 195 | $30.00 | $5,850.00 |
DisclosureSEC source: 0000784199-20-000002 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,864 F1 · price: Reflects the price of $30.00 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| January 01, 2020 Filed Jan 11, 2021 21:52 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
GrantESPP · Derivative | 79 | $16.29 Strike: $16.29 | $1,287.27 |
DisclosureSEC source: 0000784199-21-000008 · certent-form5.xml · derivative · entry 2 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79 Underlying: Common Stock · 79 shares Expires 2020-06-30 Read SEC document |
| January 01, 2020 Filed Jan 11, 2021 21:52 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
Exercise / conversionCommon Stock | 79 | $16.29 | $1,287.27 |
DisclosureSEC source: 0000784199-21-000008 · certent-form5.xml · nonDerivative · entry 1 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| January 01, 2020 Filed Jan 11, 2021 21:50 UTC |
Maier Dennis BVice President, Operations
|
GrantESPP · Derivative | 171 | $16.29 Strike: $16.29 | $2,786.36 |
DisclosureSEC source: 0000784199-21-000006 · certent-form5.xml · derivative · entry 3 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171 Underlying: Common Stock · 171 shares Expires 2020-06-30 Read SEC document |
| January 01, 2020 Filed Jan 11, 2021 21:50 UTC |
Maier Dennis BVice President, Operations
|
Exercise / conversionCommon Stock | 171 | $16.29 | $2,786.36 |
DisclosureSEC source: 0000784199-21-000006 · certent-form5.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| January 01, 2020 Filed Jan 11, 2021 21:47 UTC |
Holloway Jean FVP, General Counsel
|
GrantESPP · Derivative | 790 | $16.29 Strike: $16.29 | $12,872.66 |
DisclosureSEC source: 0000784199-21-000004 · certent-form5.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 790 Underlying: Common Stock · 790 shares Expires 2020-06-30 Read SEC document |
| January 01, 2020 Filed Jan 11, 2021 21:47 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 790 | $16.29 | $12,872.66 |
DisclosureSEC source: 0000784199-21-000004 · certent-form5.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| January 01, 2020 Filed Jan 11, 2021 21:45 UTC |
Davis John ESenior VP, Global Sales
|
GrantESPP · Derivative | 922 | $16.29 Strike: $16.29 | $15,023.53 |
DisclosureSEC source: 0000784199-21-000002 · certent-form5.xml · derivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 922 Underlying: Common Stock · 922 shares Expires 2020-06-30 Read SEC document |
| January 01, 2020 Filed Jan 11, 2021 21:45 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 922 | $16.29 | $15,023.53 |
DisclosureSEC source: 0000784199-21-000002 · certent-form5.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 31, 2019 Filed Jan 29, 2020 21:51 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
Exercise / conversionESPP · Derivative | 727 | $23.03 Strike: $23.03 | $16,740.27 |
DisclosureSEC source: 0000784199-20-000010 · certent-form5.xml · derivative · entry 3 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 727 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2019 Filed Jan 29, 2020 21:49 UTC |
Maier Dennis BVice President, Operations
|
Exercise / conversionESPP · Derivative | 118 | $23.03 Strike: $23.03 | $2,717.13 |
DisclosureSEC source: 0000784199-20-000008 · certent-form5.xml · derivative · entry 6 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 118 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2019 Filed Jan 29, 2020 21:48 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionESPP · Derivative | 356 | $23.03 Strike: $23.03 | $8,197.43 |
DisclosureSEC source: 0000784199-20-000006 · certent-form5.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 356 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:16 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionStock Options(Right to buy) · Derivative | 3,000 | $10.24 Strike: $10.24 | $30,720.00 |
DisclosureSEC source: 0000784199-19-000168 · certent-form4.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,236 Underlying: Common Stock · 3,000 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (February 19, 2016). Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:16 UTC |
Holloway Jean FVP, General Counsel
|
SaleCommon Stock | 3,000 | $26.00 | $78,000.00 |
DisclosureSEC source: 0000784199-19-000168 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,864 F1 · price: Reflects the price of $26.00 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:16 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 3,000 | $10.24 | $30,720.00 |
DisclosureSEC source: 0000784199-19-000168 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 21:13 UTC |
Capps Scott BVP, Clinical Research
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $6.12 Strike: $6.12 | $61,200.00 |
DisclosureSEC source: 0000784199-19-000166 · certent-form4.xml · derivative · entry 3 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/15/2014 Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 21:13 UTC |
Capps Scott BVP, Clinical Research
|
SaleCommon Stock | 7,184 | $24.93 | $179,107.90 |
DisclosureSEC source: 0000784199-19-000166 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,895 F1 · price: Reflects weighted average price. Range was from $24.93 to $24.99. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 21:13 UTC |
Capps Scott BVP, Clinical Research
|
Exercise / conversionCommon Stock | 10,000 | $6.12 | $61,200.00 |
DisclosureSEC source: 0000784199-19-000166 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2019 Filed Nov 19, 2019 21:43 UTC |
McCall Ronald DDirector
|
SaleCommon Stock | 4,000 | $24.64 | $98,564.80 |
DisclosureSEC source: 0000784199-19-000164 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,599 F1 · price: Reflects weighted average price. Range of prices were between $24.5 to $24.67. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2019 Filed Nov 13, 2019 21:14 UTC |
Mackin James PPresident & CEO
|
PurchaseCommon Stock | 5,000 | $23.47 | $117,355.00 |
DisclosureSEC source: 0000784199-19-000162 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,731 F1 · price: Reflects open market purchase by reporting person. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 21:32 UTC |
MORGAN HARVEYDirector
|
GiftCommon Stock | 2,319 | $23.06 | $53,476.14 |
DisclosureSEC source: 0000784199-19-000160 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,783 F1 · price: 2,319 shares were gifted by the reporting person to a trust for the benefit of his spouse for no consideration. Read SEC document |
| July 01, 2019 Filed Jan 29, 2020 21:51 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
GrantESPP · Derivative | 727 | $23.03 Strike: $23.03 | $16,740.27 |
DisclosureSEC source: 0000784199-20-000010 · certent-form5.xml · derivative · entry 2 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727 Underlying: Common Stock · 727 shares Expires 2019-12-31 Read SEC document |
| July 01, 2019 Filed Jan 29, 2020 21:51 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
Exercise / conversionCommon Stock | 727 | $23.03 | $16,740.27 |
DisclosureSEC source: 0000784199-20-000010 · certent-form5.xml · nonDerivative · entry 1 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| July 01, 2019 Filed Jan 29, 2020 21:49 UTC |
Maier Dennis BVice President, Operations
|
GrantESPP · Derivative | 118 | $23.03 Strike: $23.03 | $2,717.13 |
DisclosureSEC source: 0000784199-20-000008 · certent-form5.xml · derivative · entry 5 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118 Underlying: Common Stock · 118 shares Expires 2019-12-31 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.